Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir vs Ribavirin in Lassa Fever
NCT04907682Phase 2Completed
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Jul 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of favipiravir in Lassa fever, sponsored by Bernhard Nocht Institute for Tropical Medicine. Started Jul 2021; status: completed.
02
Drugs
favipiravir
03
Conditions
Lassa fever
Beyond the preview
Go deeper on NCT04907682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04907682.